Syndax Pharmaceuticals, Inc. (SNDX)
19.51
-0.47
(-2.35%)
USD |
NASDAQ |
Dec 09, 16:00
19.52
0.00 (0.00%)
After-Hours: 20:00
Syndax Pharmaceuticals Total Liabilities (Quarterly): 436.36M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arcutis Biotherapeutics, Inc. | 212.90M |
| ACADIA Pharmaceuticals, Inc. | 413.50M |
| Verastem, Inc. | 192.38M |
| Puma Biotechnology, Inc. | 87.59M |
| Krystal Biotech, Inc. | 102.22M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 551.79M |
| Shareholders Equity (Quarterly) | 115.43M |
| Debt to Equity Ratio | 2.993 |
| Current Ratio | 4.64 |
| Net Debt Paydown Yield | -5.15% |